HUTCHMED (CHINA) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 344 GBX | -1.71% |
|
+10.97% | +21.55% |
| 03:34pm | Hutchmed announces trials of HMPL-306 and Surufatinib cancer therapies | AN |
| 11:55am | Hutchmed Starts Phase 2/3 Trial of Surufatinib Combination Therapy in Pancreatic Cancer | MT |
2a42fc142f24.C_GXVgUiyV7bxklT0bHwdwJLFRoOmAmngPFq4fXGdho.crTtF2QWjm_okhA35cCIM08DR1JW6HHpxJ0N06O1Bmtsn_ofcBGFDuO0HA~366d2cb0d2a41883bb0a52c8a191cecb